U.S. And Europe Pharmaceutical Manufacturing Market Size, Share & Trends Analysis Report By Product Type, By Type, By Drug Development Type, By Formulation, By Routes of Administration, And Segment Forecasts, 2023 - 2030

Table of Contents

Chapter 1 Methodology and Scope
                   1.1 Market Segmentation and Scope
                       1.1.1 Segment scope
                       1.1.2 Regional scope
                       1.1.3 Estimates and forecast timeline
                   1.2 Research Methodology
                   1.3 Information Procurement
                       1.3.1 Purchased database
                       1.3.2 GVR’s internal database
                       1.3.3 Secondary sources
                       1.3.4 Primary research
                       1.3.5 Details of primary research
                   1.4 Information or Data Analysis
                       1.4.1 Data analysis models
                   1.5 Market Formulation & Validation
                   1.6 Model Details
                       1.6.1 Commodity Flow Analysis
                           1.6.1.1 Approach: Commodity Flow Approach
                   1.7 Research Assumptions
                   1.8 List of Secondary Sources
                   1.9 List of Abbreviations
                   1.10 Objectives
                       1.10.1 Objective 1
                       1.10.2 Objective 2
                       1.10.3 Objective 3
                       1.10.4 Objective 4
Chapter 2 Executive Summary
                   2.1 Market Outlook
                   2.2 Competitive Insights
Chapter 3 U.S. & Europe Pharmaceutical Manufacturing Market Variables, Trends, & Scope
                   3.1 Market Lineage Outlook
                       3.1.1 Parent market
                   3.2 Market Dynamics
                       3.2.1 Market drivers analysis
                           3.2.1.1 Rise in pharmaceutical R&D spending
                           3.2.1.2 Advancements in pharmaceutical manufacturing technologies
                           3.2.1.3 Increasing geriatric population and incidence of chronic disorders
                       3.2.2 Market restraint analysis
                           3.2.2.1 Challenges pertaining to pharma supply chain
                           3.2.2.2 Pricing pressures on pharmaceutical companies
                   3.3 Penetration & Growth Prospect Mapping
                   3.4 U.S. & Europe Pharmaceutical Manufacturing Market: Market Analysis Tools
                       3.4.1 Industry analysis - Porter’s
                       3.4.2 PESTLE analysis
                   3.5 Regulatory Framework
                   3.6 Pricing Analysis
Chapter 4 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Product Type, 2018 - 2030 (USD Billion)
                   4.1 Definition and Scope
                   4.2 Product Type Market Share Analysis, 2022 & 2030
                   4.3 Segment Dashboard
                   4.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Product Type, 2018 to 2030
                   4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       4.5.1 Small Molecule
                           4.5.1.1 Small molecule market estimates and forecast, 2018 - 2030 (USD Billion)
                       4.5.2 Large Molecule
                           4.5.2.1 Large molecule market estimates and forecast, 2018 - 2030 (USD Billion)
                               4.5.2.1.1 Monoclonal Antibodies
                                   4.5.2.1.1.1 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Billion)
                               4.5.2.1.2 Vaccines
                                   4.5.2.1.2.1 Vaccines market estimates and forecast, 2018 - 2030 (USD Billion)
                               4.5.2.1.3 Cell & Gene Therapy
                                   4.5.2.1.3.1 Cell & Gene therapy market estimates and forecast, 2018 - 2030 (USD Billion)
                               4.5.2.1.4 Others
                                   4.5.2.1.4.1 Others molecule market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 5 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Drug Development Type 2018 - 2030 (USD Billion)
                   5.1 Definition and Scope
                   5.2 Drug Development Type Market Share Analysis, 2022 & 2030
                   5.3 Segment Dashboard
                   5.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Drug Development Type, 2018 to 2030
                   5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       5.5.1 Outsource
                           5.5.1.1 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
                       5.5.2 In - house
                           5.5.2.1 In - house market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 6 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Route of Administration, 2018 - 2030 (USD Billion)
                   6.1 Definition and Scope
                   6.2 Route of Administration Market Share Analysis, 2022 & 2030
                   6.3 Segment Dashboard
                   6.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Route of Administration, 2018 to 2030
                   6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       6.5.1 Oral
                           6.5.1.1 Oral market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.5.2 Topical
                           6.5.2.1 Topical market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.5.3 Parenterals
                           6.5.3.1 Parenterals market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.5.4 Inhalations
                           6.5.4.1 Inhalations market estimates and forecast, 2018 - 2030 (USD Billion)
                       6.5.5 Others
                           6.5.5.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 7 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Formulation, 2018 - 2030 (USD Billion)
                   7.1 Definition and Scope
                   7.2 Formulation Market Share Analysis, 2022 & 2030
                   7.3 Segment Dashboard
                   7.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Formulation, 2018 to 2030
                   7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       7.5.1 Tablets
                           7.5.1.1 Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.5.2 Capsules
                           7.5.2.1 Capsules market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.5.3 Injectables
                           7.5.3.1 Injectables market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.5.4 Sprays
                           7.5.4.1 Sprays market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.5.5 Suspensions
                           7.5.5.1 Suspensions market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.5.6 Powders
                           7.5.6.1 Powders market estimates and forecast, 2018 - 2030 (USD Billion)
                       7.5.7 Others
                           7.5.7.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 8 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Therapy Area, 2018 - 2030 (USD Billion)
                   8.1 Definition and Scope
                   8.2 Therapy Area Market Share Analysis, 2022 & 2030
                   8.3 Segment Dashboard
                   8.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Therapy Area, 2018 to 2030
                   8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       8.5.1 Cardiovascular Diseases
                           8.5.1.1 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                       8.5.2 Pain
                           8.5.2.1 Pain market estimates and forecast, 2018 - 2030 (USD Billion)
                       8.5.3 Diabetes
                           8.5.3.1 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
                       8.5.4 Cancer
                           8.5.4.1 Cancer market estimates and forecast, 2018 - 2030 (USD Billion)
                       8.5.5 Respiratory Diseases
                           8.5.5.1 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Billion)
                       8.5.6 Others
                           8.5.6.1 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 9 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Prescription Requirements, 2018 - 2030 (USD Billion)
                   9.1 Definition and Scope
                   9.2 Prescription Requirements Market Share Analysis, 2022 & 2030
                   9.3 Segment Dashboard
                   9.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Prescription Requirements, 2018 to 2030
                   9.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       9.5.1 Prescription Medicines
                           9.5.1.1 Prescription medicines market estimates and forecast, 2018 - 2030 (USD Billion)
                       9.5.2 Over - the - counter (OTC) Medicines
                           9.5.2.1 Over - the - counter (OTC) medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 10 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Age Type, 2018 - 2030 (USD Billion)
                   10.1 Definition and Scope
                   10.2 Age Type Market Share Analysis, 2022 & 2030
                   10.3 Segment Dashboard
                   10.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Age Type, 2018 to 2030
                   10.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       10.5.1 Children & Adolescents
                           10.5.1.1 Children & adolescents market estimates and forecast, 2018 - 2030 (USD Billion)
                       10.5.2 Adults
                           10.5.2.1 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
                       10.5.3 Geriatric
                           10.5.3.1 Geriatric market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 11 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Sales Channel, 2018 - 2030 (USD Billion)
                   11.1 Definition and Scope
                   11.2 Sales Channel Market Share Analysis, 2022 & 2030
                   11.3 Segment Dashboard
                   11.4 U.S. & Europe Pharmaceutical Manufacturing Market, by Sales Channel, 2018 to 2030
                   11.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
                       11.5.1 Retail
                           11.5.1.1 Retail market estimates and forecast, 2018 - 2030 (USD Billion)
                       11.5.2 Non - retail
                           11.5.2.1 Non - retail market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 12 U.S. & Europe Pharmaceutical Manufacturing Market Segment Analysis, By Region, 2018 - 2030 (USD Billion)
                   12.1 Definition & Scope
                   12.2 Regional Market Share Analysis, 2022 & 2030
                   12.3 Regional Market Dashboard
                   12.4 Regional Market Snapshot
                   12.5 SWOT Analysis
                       12.5.1 U.S.
                       12.5.2 Europe
                   12.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2022 to 2030
                       12.6.1 U.S.
                           12.6.1.1 Key Country Dynamics
                           12.6.1.2 Competitive Scenario
                           12.6.1.3 Regulatory Framework
                           12.6.1.4 Reimbursement Scenario
                           12.6.1.5 U.S. market estimates and forecast, 2018 - 2030 (USD Billion)
                       12.6.2 Europe
                           12.6.2.1 Europe pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
                           12.6.2.2 U.K.
                                12.6.2.2.1 Key Country Dynamics
                                12.6.2.2.2 Competitive Scenario
                                12.6.2.2.3 Regulatory Framework
                                12.6.2.2.4 Reimbursement Scenario
                                12.6.2.2.5 U.K. pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.3 Germany
                                12.6.2.3.1 Key Country Dynamics
                                12.6.2.3.2 Competitive Scenario
                                12.6.2.3.3 Regulatory Framework
                                12.6.2.3.4 Reimbursement Scenario
                                12.6.2.3.5 Germany pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.4 Spain
                                12.6.2.4.1 Key Country Dynamics
                                12.6.2.4.2 Competitive Scenario
                                12.6.2.4.3 Regulatory Framework
                                12.6.2.4.4 Reimbursement Scenario
                                12.6.2.4.5 Spain pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.5 France
                                12.6.2.5.1 Key Country Dynamics
                                12.6.2.5.2 Competitive Scenario
                                12.6.2.5.3 Regulatory Framework
                                12.6.2.5.4 Reimbursement Scenario
                                12.6.2.5.5 France pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.6 Italy
                                12.6.2.6.1 Key Country Dynamics
                                12.6.2.6.2 Competitive Scenario
                                12.6.2.6.3 Regulatory Framework
                                12.6.2.6.4 Reimbursement Scenario
                                12.6.2.6.5 Italy pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.7 Denmark
                                12.6.2.7.1 Key Country Dynamics
                                12.6.2.7.2 Competitive Scenario
                                12.6.2.7.3 Regulatory Framework
                                12.6.2.7.4 Reimbursement Scenario
                                12.6.2.7.5 Denmark pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.8 Sweden
                                12.6.2.8.1 Key Country Dynamics
                                12.6.2.8.2 Competitive Scenario
                                12.6.2.8.3 Regulatory Framework
                                12.6.2.8.4 Reimbursement Scenario
                                12.6.2.8.5 Sweden pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
                           12.6.2.9 Norway
                                12.6.2.9.1 Key Country Dynamics
                                12.6.2.9.2 Competitive Scenario
                                12.6.2.9.3 Regulatory Framework
                                12.6.2.9.4 Reimbursement Scenario
                                12.6.2.9.5 Norway pharmaceutical manufacturing market estimates and forecast, 2018 - 2030 (USD Billion)
Chapter 13 U.S. & Europe Pharmaceutical Manufacturing Market - Competitive Analysis
                   13.1 Recent Developments & Impact Analysis, by Key Market Participants
                       13.1.1 Ansoff matrix
                       13.1.2 Heat map analysis
                       13.1.3 Major Deals and Strategic Alliances Analysis
                           13.1.3.1 Joint Ventures
                           13.1.3.2 Licensing Agreements
                           13.1.3.3 Product Launches
                           13.1.3.4 Conferences and Campaigns
                   13.2 Company Categorization
                       13.2.1 Innovators
                       13.2.2 Market Leaders
                   13.3 Vendor Landscape
                       13.3.1 List of key distributors and channel partners
                       13.3.2 Key customers
                   13.4 Public Companies
                       13.4.1 Competitive Dashboard Analysis
                           13.4.1.1 Market Differentiators
                   13.5 Private Companies
                       13.5.1 List of key emerging companies
                   13.6 Company Profiles
                       13.6.1 AbbVie Inc
                           13.6.1.1 Company overview
                           13.6.1.2 Financial performance
                           13.6.1.3 Product benchmarking
                           13.6.1.4 Strategic Initiatives
                       13.6.2 Pfizer Inc.
                           13.6.2.1 Company overview
                           13.6.2.2 Financial performance
                           13.6.2.3 Product benchmarking
                           13.6.2.4 Strategic Initiatives
                       13.6.3 Novartis AG
                           13.6.3.1 Company overview
                           13.6.3.2 Financial performance
                           13.6.3.3 Product benchmarking
                           13.6.3.4 Strategic Initiatives
                       13.6.4 F. Hoffmann - La Roche Ltd
                           13.6.4.1 Company overview
                           13.6.4.2 Financial performance
                           13.6.4.3 Product benchmarking
                           13.6.4.4 Strategic Initiatives
                       13.6.5 Merck & Co., Inc.
                           13.6.5.1 Company overview
                           13.6.5.2 Financial performance
                           13.6.5.3 Product benchmarking
                           13.6.5.4 Strategic Initiatives
                       13.6.6 Johnson & Johnson Services, Inc.
                           13.6.6.1 Company overview
                           13.6.6.2 Financial performance
                           13.6.6.3 Product benchmarking
                           13.6.6.4 Strategic Initiatives
                       13.6.7 GSK plc
                           13.6.7.1 Company overview
                           13.6.7.2 Financial performance
                           13.6.7.3 Product benchmarking
                           13.6.7.4 Strategic initiatives
                       13.6.8 Sanofi
                           13.6.8.1 Company overview
                           13.6.8.2 Financial performance
                           13.6.8.3 Product benchmarking
                           13.6.8.4 Strategic initiatives
                       13.6.9 Lonza
                           13.6.9.1 Company overview
                           13.6.9.2 Financial performance
                           13.6.9.3 Product benchmarking
                           13.6.9.4 Strategic initiatives
                       13.6.10 Samsung Biologics
                           13.6.10.1 Company overview
                           13.6.10.2 Financial performance
                           13.6.10.3 Product benchmarking
                           13.6.10.4 Strategic initiatives
                       13.6.11 Lilly
                           13.6.11.1 Company overview
                           13.6.11.2 Financial performance
                           13.6.11.3 Product benchmarking
                           13.6.11.4 Strategic initiatives

List of Tables

Table 1 List of Secondary Sources
Table 2 List of Abbreviations
Table 3 Leading Market Players Anticipated to Witness Highest Growth
Table 4 U.S. & Europe Pharmaceutical Manufacturing Market, By Region, 2018 - 2030 (USD Billion)
Table 5 U.S. & Europe Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 6 U.S. & Europe Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 7 U.S. & Europe Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 8 U.S. & Europe Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 9 U.S. & Europe Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 10 U.S. & Europe Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 11 U.S. & Europe Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 12 U.S. & Europe Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 13 U.S. Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 14 U.S. Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 15 U.S. Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 16 U.S. Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 17 U.S. Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 18 U.S. Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 19 U.S. Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 20 U.S. Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 21 Europe Pharmaceutical Manufacturing Market, By Country, 2018 - 2030 (USD Billion)
Table 22 Europe Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 23 Europe Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 24 Europe Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 25 Europe Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 26 Europe Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 27 Europe Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 28 Europe Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 29 Europe Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 30 Germany Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 31 Germany Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 32 Germany Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 33 Germany Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 34 Germany Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 35 Germany Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 36 Germany Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 37 Germany Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 38 U.K. Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 39 U.K. Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 40 U.K. Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 41 U.K. Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 42 U.K. Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 43 U.K. Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 44 U.K. Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 45 U.K. Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 46 France Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 47 France Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 48 France Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 49 France Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 50 France Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 51 France Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 52 France Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 53 France Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 54 Italy Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 55 Italy Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 56 Italy Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 57 Italy Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 58 Italy Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 59 Italy Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 60 Italy Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 61 Italy Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 62 Spain Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 63 Spain Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 64 Spain Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 65 Spain Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 66 Spain Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 67 Spain Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 68 Spain Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 69 Spain Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 70 Norway Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 71 Norway Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 72 Norway Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 73 Norway Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 74 Norway Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 75 Norway Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 76 Norway Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 77 Norway Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 78 Denmark Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 79 Denmark Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 80 Denmark Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 81 Denmark Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 82 Denmark Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 83 Denmark Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 84 Denmark Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 85 Denmark Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)
Table 86 Sweden Pharmaceutical Manufacturing Market, By Product Type, 2018 - 2030 (USD Billion)
Table 87 Sweden Pharmaceutical Manufacturing Market, By Drug Development Type, 2018 - 2030 (USD Billion)
Table 88 Sweden Pharmaceutical Manufacturing Market, By Route of Administration, 2018 - 2030 (USD Billion)
Table 89 Sweden Pharmaceutical Manufacturing Market, By Formulation, 2018 - 2030 (USD Billion)
Table 90 Sweden Pharmaceutical Manufacturing Market, By Therapy Area, 2018 - 2030 (USD Billion)
Table 91 Sweden Pharmaceutical Manufacturing Market, By Prescription Requirements, 2018 - 2030 (USD Billion)
Table 92 Sweden Pharmaceutical Manufacturing Market, By Age Type, 2018 - 2030 (USD Billion)
Table 93 Sweden Pharmaceutical Manufacturing Market, By Sales Channel, 2018 - 2030 (USD Billion)

List of Figures

Fig. 1 U.S. & Europe pharmaceutical manufacturing market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2022)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 U.S. & Europe pharmaceutical manufacturing market: Product Type movement analysis
Fig. 17 U.S. & Europe pharmaceutical manufacturing market: Product Type segment dashboard
Fig. 18 U.S. & Europe pharmaceutical manufacturing market Product Type outlook: Key takeaways
Fig. 19 Small molecule market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 20 Large molecule market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 21 Monoclonal antibodies market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 22 Vaccines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 23 Cell & gene therapy market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 24 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 25 U.S. & Europe pharmaceutical manufacturing market: Drug development type movement analysis
Fig. 26 U.S. & Europe pharmaceutical manufacturing market: Drug development type segment dashboard
Fig. 27 U.S. & Europe pharmaceutical manufacturing market Drug development type outlook: Key takeaways
Fig. 28 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 29 Outsource market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 30 U.S. & Europe pharmaceutical manufacturing market: Route of administration movement analysis
Fig. 31 U.S. & Europe pharmaceutical manufacturing market: Route of administration segment dashboard
Fig. 32 U.S. & Europe pharmaceutical manufacturing market Route of administration outlook: Key takeaways
Fig. 33 Oral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 34 Topical market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 35 Parenteral market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 36 Inhalations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 37 Inhalations market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 38 U.S. & Europe pharmaceutical manufacturing market: Formulation movement analysis
Fig. 39 U.S. & Europe pharmaceutical manufacturing market: Formulation segment dashboard
Fig. 40 U.S. & Europe pharmaceutical manufacturing market Formulation outlook: Key takeaways
Fig. 41 Tablets market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 42 Capsules market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 43 Injectables market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 44 Sprays market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 45 Suspensions market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 46 Powders market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 47 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 48 U.S. & Europe pharmaceutical manufacturing market: Therapy area movement analysis
Fig. 49 U.S. & Europe pharmaceutical manufacturing market: Therapy area segment dashboard
Fig. 50 U.S. & Europe pharmaceutical manufacturing market Therapy area outlook: Key takeaways
Fig. 51 Cardiovascular diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 52 Pain market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 53 Diabetes market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 54 Cancer market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 55 Respiratory diseases market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 56 Others market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 57 U.S. & Europe pharmaceutical manufacturing market: Prescription requirements movement analysis
Fig. 58 U.S. & Europe pharmaceutical manufacturing market: Prescription requirements segment dashboard
Fig. 59 U.S. & Europe pharmaceutical manufacturing market Prescription requirements outlook: Key takeaways
Fig. 60 Prescription medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 61 Over-the-counter (OTC) medicines market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 62 U.S. & Europe pharmaceutical manufacturing market: Age type movement analysis
Fig. 63 U.S. & Europe pharmaceutical manufacturing market: Age type segment dashboard
Fig. 64 U.S. & Europe pharmaceutical manufacturing market Age type outlook: Key takeaways
Fig. 65 Children & adolescents market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 66 Adults market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 67 Geriatric market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 68 U.S. & Europe pharmaceutical manufacturing market: Sales channel movement analysis
Fig. 69 U.S. & Europe pharmaceutical manufacturing market: Sales channel segment dashboard
Fig. 70 U.S. & Europe pharmaceutical manufacturing market Sales channel outlook: Key takeaways
Fig. 71 Retail market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 72 Non-retail market estimates and forecast, 2018 - 2030 (USD Billion)
Fig. 73 Regional outlook, 2022 & 2030
Fig. 74 Regional market dashboard
Fig. 75 Regional market place: Key takeaways
Fig. 76 U.S, SWOT
Fig. 77 Europe, SWOT
Fig. 78 U.S.
Fig. 79 U.S. pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 80 Europe
Fig. 81 Europe pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 82 U.K.
Fig. 83 U.K. pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 84 Germany
Fig. 85 Germany pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 86 Spain
Fig. 87 Spain pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 88 France
Fig. 89 France pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 90 Italy
Fig. 91 Italy pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 92 Denmark
Fig. 93 Denmark pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 94 Norway
Fig. 95 Norway pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 96 Sweden
Fig. 97 Sweden pharmaceutical manufacturing market, 2018 - 2030 (USD Billion)
Fig. 98 Ansoff Matrix
Fig. 99 Heat map analysis
Fig. 100 Market differentiators